Pharmacological Interventions

The use of medication to manage withdrawal symptoms, reduce cravings, or treat co-occurring mental health disorders e.g., methadone, buprenorphine, naltrexone.

A European Guide on Dual disorders: Health and Social Responses

Guide

21 May 2026

This European guide by EUDA highlights the importance of addressing dual disorders, where mental health conditions and substance use disorders occur at the same time. These co-occurring conditions are common and often lead to poorer health...

Measuring meaningful outcomes in research into pharmacotherapies for people living with methamphetamine dependence: Findings from a systematic review, and lived and living experience perspectives

23 April 2026

Online

Australia

Time: April 23, 2026 @ 12PM Australian Eastern Standard Time

GLP-1 RAs and Substance Use Disorder Treatment: The Potential and Emerging Challenges

Leaflet, Infographic, Fact sheet, Poster

30 October 2025

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the management of type 2 diabetes and obesity. Exciting new research suggests these medications may also hold immense promise for treating substance use...

Seasonal Variations in Treatment Seeking for Alcohol Use Disorder in the Total Danish Population

Scientific article

15 October 2024

A significant number of individuals with alcohol use disorder (AUD) do not seek treatment, and the factors influencing treatment-seeking behavior are not well understood. While it is known that alcohol consumption levels can fluctuate with...